Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Prospective study of the correlation of ctDNA with pathologic complete remission (pCR) and other efficacy outcomes in rectal cancer patients undergoing neoadjuvant chemotherapy and radiation.
Authors
RuoBing Xue
James Graham Brown Cancer Center, University of Louisville, Louisville, KY
RuoBing Xue , Vivek R. Sharma , Russell Ware Farmer , Shesh Rai , Xiaoyong Wu , Michael Krainock , Bridgette Drummond , Perry Olshan , Paul R. Billings , Alexey Aleshin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.TPS235
Abstract #
TPS235
Poster Bd #
P4
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
The efficacy of neoadjuvant treatment in locally advanced rectal cancer with dMMR.
First Author: Yanhong Deng
Poster
2024 ASCO Breakthrough
Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.
First Author: Yoshinori Kagawa
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of neoadjuvant preoperative short-course radiation followed by envafolimab plus CAPEOX in microsatellite stable (MSS)/mismatch repair proficient (pMMR) locally advanced rectal cancer.
First Author: Sheng Dai
Poster
2022 ASCO Annual Meeting
EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors.
First Author: Kristen Keon Ciombor